Jan Nouwen

6.1k total citations · 1 hit paper
48 papers, 4.1k citations indexed

About

Jan Nouwen is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Jan Nouwen has authored 48 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 15 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Jan Nouwen's work include Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Streptococcal Infections and Treatments (9 papers). Jan Nouwen is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Streptococcal Infections and Treatments (9 papers). Jan Nouwen collaborates with scholars based in Netherlands, United States and Indonesia. Jan Nouwen's co-authors include Alex van Belkum, Henri A. Verbrugh, Heiman Wertheim, Damian C. Melles∗, Martine De Vos, Willem van Leeuwen, Hélène Boelens, H.A. Verbrugh, Jan Kluytmans and Nelianne J. Verkaik and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jan Nouwen

44 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of nasal carriage in Staphylococcus aureus infections

2005 2.0k citations Heiman Wertheim, Damian C. Melles∗ et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Jan Nouwen

Since Specialization

Citations

This map shows the geographic impact of Jan Nouwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Nouwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Nouwen more than expected).

Fields of papers citing papers by Jan Nouwen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Nouwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Nouwen. The network helps show where Jan Nouwen may publish in the future.

Co-authorship network of co-authors of Jan Nouwen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Nouwen. A scholar is included among the top collaborators of Jan Nouwen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Nouwen. Jan Nouwen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV-Associated Dermatological Alterations: Barrier Dysfunction, Immune Impairment, and Microbiome Changes 2025 ·International Journal of Molecular Sciences ·(unknown), Handono Kalim, Jan Nouwen, Hok Bing Thio	0
2	Butyrate Properties in Immune-Related Diseases: Friend or Foe? 2023 ·Fermentation ·(unknown), (unknown), Handono Kalim, Reiva Farah Dwiyana, Oki Suwarsa, Tamar Nijsten, Jan Nouwen, Hok Bing Thio	33
3	Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial 2017 ·The Lancet HIV ·(unknown), Casper Rokx, Charles A. Boucher, Jeroen J. A. van Kampen, Suzan D. Pas, (unknown), Carolina A. M. Schurink, Hannelore I. Bax, Maarten Derksen, Eleni‐Rosalina Andrinopoulou, Marchina van der Ende, Eric C. M. Van Gorp, Jan Nouwen, Annelies Verbon, Wouter F.W. Bierman, Bart Rijnders	76
4	Cost-Effectiveness of PrEP in HIV/AIDS Control in Zambia 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Brooke E Nichols, Rob Baltussen, Janneke H. van Dijk, Philip E. Thuma, Jan Nouwen, Charles A. Boucher, David van de Vijver	23
5	Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice 2013 ·PLoS ONE ·Sanne van den Berg, Jon D. Laman, Louis Boon, Marian T. ten Kate, Gerjo J. de Knegt, Robert M. Verdijk, Henri A. Verbrugh, Jan Nouwen, Irma A. J. M. Bakker‐Woudenberg	22
6	Prevalence of nasal methicillin-resistant Staphylococcus aureus colonization in healthcare workers in a Western Australian acute care hospital 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), James O. Robinson, Geoffrey W. Coombs, (unknown), Ronan J. Murray, Henri A. Verbrugh, Thomas V. Riley, Jan Nouwen, K. J. Christiansen	24
7	Reclassification of Staphylococcus aureus Nasal Carriage Types 2009 ·The Journal of Infectious Diseases ·Alex van Belkum, Nelianne J. Verkaik, Corné P. de Vogel, Hélène Boelens, (unknown), Jan Nouwen, Henri A. Verbrugh, Heiman Wertheim	313
8	Histoplasma-associated inflammatory pseudotumour of the kidney mimicking renal carcinoma 2009 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Michael A. den Bakker, Natascha Goemaere, Juliëtte A. Severin, Jan Nouwen, Paul C.M.S. Verhagen	10
9	Eradication of Methicillin‐ResistantStaphylococcus aureusCarriage: A Systematic Review 2009 ·Clinical Infectious Diseases ·Heidi Ammerlaan, Jan Kluytmans, Heiman Wertheim, Jan Nouwen, Marc J. M. Bonten	187
10	Host Polymorphisms in Interleukin 4, Complement Factor H, and C‐Reactive Protein Associated with Nasal Carriage ofStaphylococcus aureusand Occurrence of Boils 2008 ·The Journal of Infectious Diseases ·Marieke Emonts, André G. Uitterlinden, Jan Nouwen, Isabella Kardys, Moniek P.M. de Maat, Damian C. Melles∗, Jacqueline C.M. Witteman, Paulus T. V. M. de Jong, Henri A. Verbrugh, Albert Hofman, Peter W. M. Hermans, Alex van Belkum	68
11	Low carriage rate of group B streptococcus in pregnant women in Maputo, Mozambique 2008 ·Tropical Medicine & International Health ·(unknown), (unknown), Anouk E. Muller, Jan Nouwen, Paul M. Oostvogel, Sibone Mocumbi	31
12	The role of human innate immune factors in nasal colonization by Staphylococcus aureus 2007 ·Microbes and Infection ·Alex van Belkum, Marieke Emonts, Heiman Wertheim, Christa E. van der Gaast‐de Jongh, Jan Nouwen, (unknown), Alexander M. Cole, Amy L. Cole, Peter W. M. Hermans, Hélène Boelens, Nicole Lemmens‐den Toom, Susan V. Snijders, Henri A. Verbrugh, Willem van Leeuwen	56
13	Host–microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients 2007 ·Microbes and Infection ·Damian C. Melles∗, (unknown), (unknown), Hélène Boelens, (unknown), Justine Peeters, Hanneke Witsenboer, Willem B. van Leeuwen, Henri A. Verbrugh, Alex van Belkum, Jan Nouwen	17
14	Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus. 2006 ·Oxford University Research Archive (ORA) (University of Oxford) ·A.F. vanBelkum, Damian C. Melles∗, Susan V. Snijders, (unknown), (unknown), Jan Nouwen, Henri A. Verbrugh, (unknown)	7
15	Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. 2006 ·Jan Nouwen, Jan Schouten, (unknown), Susan V. Snijders, Jolanda Maaskant, M. I. Koolen, A.F. vanBelkum, H.A. Verbrugh	1
16	Persistent (not intermittent) nasal carriage ofStaphylococcus aureus is the determinant of CPD-related infections 2005 ·Kidney International ·Jan Nouwen, M. W. J. A. Fieren, Susan V. Snijders, Henri A. Verbrugh, Alex van Belkum	100
17	The role of nasal carriage in Staphylococcus aureus infections breakdown → 2005 ·The Lancet Infectious Diseases ·Heiman Wertheim, Damian C. Melles∗, Martine De Vos, Willem van Leeuwen, Alex van Belkum, Henri A. Verbrugh, Jan Nouwen	1983
18	Human factor in Staphylococcus aureus nasal carriage 2004 ·Jan Nouwen, Hélène Boelens, A.F. vanBelkum, H.A. Verbrugh	4
19	Staphylococcus aureusnasal carriage is not associated with known polymorphism in the Vitamin D receptor gene 2004 ·FEMS Immunology & Medical Microbiology ·Mark A. A. Claassen, Jan Nouwen, Yue Fang, Alewijn Ott, Henri A. Verbrugh, Albert Hofman, Alex van Belkum, André G. Uitterlinden	22
20	Predicting the Staphylococcus aureus Nasal Carrier State: Derivation and Validation of a "Culture Rule" 2004 ·Clinical Infectious Diseases ·Jan Nouwen, Alewijn Ott, Marjolein Kluytmans-van den Bergh, Hélène Boelens, Amy Hofman, Alex van Belkum, H.A. Verbrugh	190

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact